Stoneridge Investment Partners LLC Sells 52,258 Shares of Baxter International Inc. $BAX

Key Points

• Stoneridge Investment Partners LLC reduced its holdings in Baxter International by 65.5%, now owning 27,583 shares worth approximately $944,000 after selling 52,258 shares in the 1st quarter.
• Several large investors increased their stakes in Baxter International, with SG Americas Securities LLC growing its holdings by 352.6% and Raiffeisen Bank International AG by 24.9%.
• Baxter International's stock received multiple target price reductions from analysts, with Barclays lowering it from $41 to $36 and UBS Group from $35 to $24, indicating a consensus rating of "Hold."

Stoneridge Investment Partners LLC decreased its position in Baxter International Inc. (NYSE:BAX - Free Report) by 65.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,583 shares of the medical instruments supplier's stock after selling 52,258 shares during the period. Stoneridge Investment Partners LLC's holdings in Baxter International were worth $944,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Zions Bancorporation National Association UT acquired a new position in shares of Baxter International in the 1st quarter worth approximately $27,000. Rossby Financial LCC acquired a new stake in shares of Baxter International in the 1st quarter worth $29,000. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Baxter International by 48.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 2,021 shares of the medical instruments supplier's stock valued at $69,000 after purchasing an additional 656 shares during the period. Archer Investment Corp increased its holdings in Baxter International by 20.5% during the 1st quarter. Archer Investment Corp now owns 2,935 shares of the medical instruments supplier's stock valued at $100,000 after acquiring an additional 500 shares in the last quarter. Finally, Bruce G. Allen Investments LLC grew its holdings in shares of Baxter International by 35.2% during the first quarter. Bruce G. Allen Investments LLC now owns 3,546 shares of the medical instruments supplier's stock worth $121,000 after buying an additional 924 shares in the last quarter. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on BAX shares. Citigroup reduced their price target on shares of Baxter International from $34.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 9th. Wall Street Zen downgraded Baxter International from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Morgan Stanley decreased their target price on Baxter International from $28.00 to $27.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Barclays lowered their price objective on shares of Baxter International from $41.00 to $36.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, The Goldman Sachs Group cut Baxter International from a "buy" rating to a "neutral" rating and set a $25.00 target price for the company. in a research report on Friday, August 1st. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $30.11.

Baxter International Price Performance

Baxter International stock traded up $0.0350 during midday trading on Monday, reaching $24.5750. The company's stock had a trading volume of 4,410,462 shares, compared to its average volume of 5,311,651. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. The stock has a market cap of $12.62 billion, a PE ratio of -81.97, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. Baxter International Inc. has a 52 week low of $21.33 and a 52 week high of $40.49. The business has a 50-day moving average price of $27.46 and a 200-day moving average price of $30.16.

Baxter International (NYSE:BAX - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 EPS for the quarter, missing the consensus estimate of $0.60 by ($0.01). Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.The business had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.82 billion. During the same period in the previous year, the firm posted $0.68 EPS. The firm's revenue was up 4.3% compared to the same quarter last year. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. On average, sell-side analysts predict that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, August 29th will be issued a $0.17 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.68 annualized dividend and a yield of 2.8%. Baxter International's dividend payout ratio is presently -226.67%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.